A. de Remigis

发表

Hashimoto thyroiditis: clinical and diagnostic criteria.

N. Rose, P. Caturegli, N R Rose, 2014, Autoimmunity reviews.

Pituitary Expression of CTLA-4 Mediates Hypophysitis Secondary to Administration of CTLA-4 Blocking Antibody

J. Wolchok, M. Callahan, S. Slovin, 2014, Science Translational Medicine.

Hashimoto's thyroiditis: celebrating the centennial through the lens of the Johns Hopkins hospital surgical pathology records.

M. Dembele, P. Caturegli, Shintaro Iwama, 2013, Thyroid : official journal of the American Thyroid Association.

Hürthle cells predict hypothyroidism in interferon-γ transgenic mice of different genetic backgrounds.

J. Bishop, Hiroaki Kimura, P. Caturegli, 2012, Endocrinology.

Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival

E. Jaffee, T. D. de Gruijl, D. Laheru, 2015, International journal of cancer.

Thyroid dysfunctions secondary to cancer immunotherapy

G. Di Dalmazi, P. Caturegli, F. Pani, 2018, Journal of Endocrinological Investigation.

Detection of pituitary antibodies by immunofluorescence: approach and results in patients with pituitary diseases.

F. Guaraldi, G. Wand, P. Caturegli, 2014, The Journal of clinical endocrinology and metabolism.

Impact of semaglutide on high-sensitivity C-reactive protein: exploratory patient-level analyses of SUSTAIN and PIONEER randomized clinical trials

J. Rosenstock, P. Weimers, Ofri Mosenzon, 2022, Cardiovascular Diabetology.

Semaglutide reduces cardiovascular events regardless of metformin use: a post hoc subgroup analysis of SUSTAIN 6 and PIONEER 6

A. Consoli, M. Husain, S. Rasmussen, 2022, Cardiovascular Diabetology.

Anatabine ameliorates experimental autoimmune thyroiditis.

M. Ferlito, P. Ladenson, Shey-Cherng Tzou, 2012, Endocrinology.

Association of Interleukin 6 Inhibition With Ziltivekimab and the Neutrophil-Lymphocyte Ratio

P. Libby, P. Ridker, J. Cornel, 2022, JAMA cardiology.